LANCE WILLIAMSON: Open Payments
NPI 1114285723 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 23 payments from 6 companies in 2025. Trend: 2023 $838 · 2024 $1,045 · 2025 $466
Food & beverage: $464Education: $2
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 7 | $158 |
| Travere Therapeutics, Inc. | 8 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
Products named: VELPHORO, Fabhalta, FUROSCIX, TARPEYO, IBSRELA, Filspari.
Industry payments across KY — which companies pay providers there.
